- Global Pharma News & Resources

Bioness Introduces Key Updates to Rehabilitation Technology at the American Physical Therapy Association's Combined Sections Meeting

Bioness Introduces Key Updates to Rehabilitation Technology at the American Physical Therapy Association's Combined Sections Meeting Technology updates provide clinicians new training options for patients to maximize therapy sessions

PR Newswire

VALENCIA, Calif., Jan. 22, 2019

VALENCIA, Calif., Jan. 22, 2019 /PRNewswire/ -- Bioness, Inc., the leading provider of state-of-the-art, clinically supported rehabilitation and pain management medical devices, will be highlighting key updates to the L300 Go™ FES system and Vector® Gait and Safety System at this year's American Physical Therapy Association's Combined Sections Meeting being held in Washington D.C. from January 23-26, 2019.

For the first time ever, Bioness will offer L300 Go Cycle Training Mode which will allow users of the L300 Go System to train and exercise on a stationary bike. Therapists can now use custom timing settings to easily configure stationary bikes for patients to use with the L300 Go in their clinics.  In addition, the improved Thigh Stand-Alone with 3D motion detection technology eliminates the need for a foot sensor ensuring a simple and easy setup with accurate stimulation meant to provide patients greater control of flexion or extension of the knee for a more natural gait.  It's Improved Mobility. Made Easier.™

The Vector Gait and Safety System is the global leader in over-ground body weight support systems and with the launch of Vector 2.2 software, continues to improve. New Force-based Active Body Control provides the ability to perform an extensive variety of exercises while actively preventing falls. Equally important, treadmill training has been integrated with the Biodex Trainer 3, allowing you to control the Vector Elite System and treadmill with one simple-to-use interface.

"With the new developments showcased at this year's APTA-CSM we've strengthened our position as the technology leader in rehab by empowering therapists with new features that will drive meaningful outcomes for their patients," saidTodd Cushman, President and CEO of Bioness.  "Bioness continues its commitment to innovation by driving breakthroughs and developing the most effective technology for rehabilitation professionals in skilled, acute, inpatient and outpatient practices."

Bioness will also feature the Company's complete portfolio of innovative clinical solutions in Booth #719, including the following:

BITS® Bedside & Mobile Configurations
Most rehabilitation activities are designed to be performed from a standing position, however, many rehab patients are confined to their beds or restricted to seated activities for medical or safety reasons. To help tackle this challenge, Bioness has developed the BITS Bedside & Mobile configurations. The BITS Bedside configuration allows clinicians to engage rehab patients right at the bedside facilitating rehabilitative exercises for non-ambulatory patients. The BITS Mobile configuration is highly adaptable to challenging rehab environments where a full rehab gym is not available. With the BITS Bedside & Mobile configurations, clinicians can challenge and assess patients' physical, visual, auditory, and cognitive abilities in virtually any treatment area. The BITS 2.0 software provides the ability to track and document progress with the goal of keeping patients engaged during this important phase of care.

H200® Wireless Hand Rehabilitation System
With more than 20 peer-reviewed and published clinical studies, the H200 System has been clinically shown to improve hand and upper extremity function during all stages of stroke rehabilitation. The System delivers non-invasive, functional electrical stimulation (FES) to improve hand function, reduce muscle spasms and prevent disuse atrophy. H200 Wireless is widely used in the Veterans Administration to promote functional hand use in spinal cord injury patients that lack the ability to perform daily activities including grasping and releasing hand movements.

StimRouter® Neuromodulation System for Chronic Peripheral Pain
With an estimated 100 million people suffering from chronic pain, contributing more than $280 billion in annual costs to the U.S. healthcare system, there's never been a greater need for innovative pain management options.1 Specific to rehabilitation, shoulder pain is a common disability resulting from a central nervous system trauma (e.g. stroke). This pain traditionally originates at the axillary nerve, a peripheral nerve in the upper arm, and has been reported to occur in up to 85% of stroke survivors.2 The StimRouter is an implanted neuromodulation system designed to treat chronic pain of peripheral nerve origin (excluding the cranial facial region) by directly targeting pain at its point of origin, as an adjunct to other modes of therapy (e.g. medications). StimRouter helps minimize long-term healthcare costs and may provide pain relief compared to other treatments such as medications and injections which often have limited effect.3

About Bioness, Inc.
Bioness is the leading provider of innovative technologies helping people regain mobility and independence. Bioness solutions include implantable and external neuromodulation systems, robotic systems, and software-based therapy programs providing functional and therapeutic benefits for individuals affected by pain, central nervous system disorders, and orthopedic injuries. Currently, Bioness offers six medical devices within its commercial portfolio which are distributed and sold on five continents and in over 25 countries worldwide. Our technologies have been implemented in the most prestigious and well-respected institutions around the globe with approximately 90% of the top rehabilitation hospitals in the United States currently using one or more Bioness solutions.  Bioness has a singular focus on aiding large, underserved customer groups with innovative, evidence-based solutions and we will continue to develop and make commercially available new products that address the growing and changing needs of our customers. Individual results vary. Consult with a qualified physician to determine if this product is right for you. Contraindications, adverse reactions and precautions are available online at

Media Relations Contact Information
Next Step Communications

Bioness®, BITS®, H200®, and StimRouter™ are trademarks of Bioness, Inc. | | Rx Only for applicable products.

1 Institute of Medicine (US). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research. 2011. The National Academies.
2 Van Ouwenaller, C. et al. 1986. Archives of Physical Medicine and Rehabilitation. 67, 23–26.
3 Deer T, et al. 2016. Neuromodulation. 19:91-100.


View original content to download multimedia:

SOURCE Bioness, Inc.

Editor Details

Last Updated: 22-Jan-2019